4Franzke A, Piao W, Lauber J, et al. G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transp lantation and autoimmune diseases. Blood, 2003; 102(2) : 734 - 739.
5Morris ES, MacDonald KP, Rowe V, et al. Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance. Blood,2004; 103(9):3573 - 3581.
6Chen SH, Li X, Huang XJ. Effect of recombinant human granulo- cyte colony-stimulating factor on T-lymphocyte function and the mechanism of this effect. Int J Hematol, 2004; 79(2) : 178 - 184.
7Jun HX, Jun CY, Yu ZX. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor. Haema- tologica, 2004; 89(12) :1517- 1524.
8Morris ES, MacDonald KP, Hill GR. Stem cellmobilization with G-CSF analogs: a rational app roach to separate GVHD and GVL? Blood, 2006; 107(9) : 3430 -3435.
9Jun HX, Jun CY, Yu ZX. A direct comparison of immunological characteristics of granulocyte colony-stimulating factor (G-CSF) - primed bone marrow grafts and G-CSF-mobilized peripheral blood grafts. Haematologica, 2005 ; 90 (5) : 715 - 716.
10Yi T, Chen Y, Wang L, et al. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft versus host disease. Blood, 2009; 114(14) : 3101 -3112.
